Literature DB >> 25378999

Red ginseng and H5N1 influenza infection.

Viroj Wiwanitkit1.   

Abstract

Entities:  

Year:  2014        PMID: 25378999      PMCID: PMC4213816          DOI: 10.1016/j.jgr.2014.05.003

Source DB:  PubMed          Journal:  J Ginseng Res        ISSN: 1226-8453            Impact factor:   6.060


× No keyword cloud information.
The recent report on “Red Ginseng and H5N1 influenza infection” in this journal is very interesting [1]. Park et al [1] noted that “the diet with the immune-enhancing Red Ginseng could help humans to overcome the infections by HP H5N1 influenza virus.” In fact, the effect of ginseng on immunomodulation has previously been confirmed and it has been proposed that ginseng can be useful in improving immunity to fight infection [2]. Lee et al [2] noted that ginseng can help to stimulate antiviral cytokine IFN-γ production after influenza A virus infection and inhibit the infiltration of inflammatory cells into the bronchial lumen. Yoo et al [3] have reported that “red ginseng extract showed significantly enhanced protection, lower levels of lung viral titers and interleukin-6.” In-depth biochemical analysis has shown that the polysaccharide in the extract is the main part that contributes to the counteracting function towards the influenza virus [4]. In addition, it has also been reported that Red Ginseng extract could enhance the protection derived from influenza vaccination [5]. Hence, there is no doubt that ginseng as a food supplement can be useful against influenza. In human studies, some workers have reported that Red Ginseng can be useful in improving acute respiratory illness [6] as well as influenza-like illnesses [7]. In a study in humans, the protective effect of ginseng on human endothelial cells against avian influenza virus has been reported in vitro [8]. However, there has not yet been a reliable clinical trial on influenza in humans. There are still topics for further study, including: verification of the usefulness of ginseng extract in humans; standardization of the commercially available ginseng extracts; and the development of a health body which can give information to users about the effectiveness and safety of ginseng supplementation. As noted by Kaneko and Nakanishi [9], the effect of ginseng is mysterious and most data are from subjective clinical observations; further research on this topic is required. Finally, the safety of using ginseng in humans should also be mentioned. Although ginseng is considered safe, some rare adverse effects, such as anaphylaxis, have been reported [10]. In a human study evaluating the role of ginseng extract in potentiating the influenza vaccine, many adverse effects were recorded, especially insomnia [11].

Conflicts of interest

The author declares no conflicts of interest.
  11 in total

Review 1.  Proof of the mysterious efficacy of ginseng: basic and clinical trials: clinical effects of medical ginseng, korean red ginseng: specifically, its anti-stress action for prevention of disease.

Authors:  Hitoshi Kaneko; Kozo Nakanishi
Journal:  J Pharmacol Sci       Date:  2004-06       Impact factor: 3.337

2.  Efficacy and safety of the standardised Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold [corrected].

Authors:  F Scaglione; G Cattaneo; M Alessandria; R Cogo
Journal:  Drugs Exp Clin Res       Date:  1996

3.  Dual functions of ginsenosides in protecting human endothelial cells against influenza H9N2-induced inflammation and apoptosis.

Authors:  Lok Yung Chan; Hoi Hin Kwok; Renee Wan Yi Chan; Malik Joseph Sriyal Peiris; Nai Ki Mak; Ricky Ngok Shun Wong; Michael Chi Wai Chan; Patrick Ying Kit Yue
Journal:  J Ethnopharmacol       Date:  2011-08-22       Impact factor: 4.360

4.  A comparative study of the effects of whole red ginseng extract and polysaccharide and saponin fractions on influenza A (H1N1) virus infection.

Authors:  Sun Young Yin; Hyoung Jin Kim; Hong-Jin Kim
Journal:  Biol Pharm Bull       Date:  2013       Impact factor: 2.233

5.  Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice.

Authors:  Dae-Goon Yoo; Min-Chul Kim; Min-Kyung Park; Jae-Min Song; Fu-Shi Quan; Kyoung-Mi Park; Young-Keol Cho; Sang-Moo Kang
Journal:  J Med Food       Date:  2012-08-02       Impact factor: 2.786

6.  A placebo-controlled trial of Korean red ginseng extract for preventing influenza-like illness in healthy adults.

Authors:  Ki-Chan Ha; Min-Gul Kim; Mi-Ra Oh; Eun-Kyung Choi; Hyang-Im Back; Sun-Young Kim; Eun-Ok Park; Dae-Young Kwon; Hye-Jeong Yang; Min-Jeong Kim; Hee-Joo Kang; Ju-Hyung Lee; Kyung-Min Choi; Soo-Wan Chae; Chang-Seop Lee
Journal:  BMC Complement Altern Med       Date:  2012-02-08       Impact factor: 3.659

7.  Intake of korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza a virus.

Authors:  Mei Ling Xu; Hyoung Jin Kim; Yoo Ri Choi; Hong-Jin Kim
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

8.  Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial.

Authors:  Chang-Seop Lee; Ju-Hyung Lee; Mira Oh; Kyung-Min Choi; Mi Ran Jeong; Jong-Dae Park; Dae Young Kwon; Ki-Chan Ha; Eun-Ock Park; Nuri Lee; Sun-Young Kim; Eun-Kyung Choi; Min-Gul Kim; Soo-Wan Chae
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

9.  Red Ginseng-containing diet helps to protect mice and ferrets from the lethal infection by highly pathogenic H5N1 influenza virus.

Authors:  Eun Hye Park; Jung Yum; Keun Bon Ku; Heui Man Kim; Young Myong Kang; Jeong Cheol Kim; Ji An Kim; Yoo Kyung Kang; Sang Heui Seo
Journal:  J Ginseng Res       Date:  2013-12-08       Impact factor: 6.060

10.  Immunomodulatory activity of red ginseng against influenza A virus infection.

Authors:  Jong Seok Lee; Hye Suk Hwang; Eun-Ju Ko; Yu-Na Lee; Young-Man Kwon; Min-Chul Kim; Sang-Moo Kang
Journal:  Nutrients       Date:  2014-01-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.